Legato Capital Management LLC Revance Therapeutics, Inc. Transaction History

Legato Capital Management LLC

  • $761 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$4.65 - $9.31 $205,483 - $411,408
44,190 Added 76.65%
101,842 $501,000
Q4 2023

Jan 16, 2024
BUY
$5.81 - $11.2 $109,826 - $211,713
18,903 Added 48.78%
57,652 $506,000
Q3 2023

Oct 12, 2023
SELL
$11.47 - $25.07 $11,664 - $25,496
-1,017 Reduced 2.56%
38,749 $444,000
Q2 2023

Aug 17, 2023
BUY
$24.7 - $37.61 $156,202 - $237,845
6,324 Added 18.91%
39,766 $1.01 Million
Q4 2022

Feb 01, 2023
BUY
$18.32 - $30.66 $612,657 - $1.03 Million
33,442 New
33,442 $617,000

Others Institutions Holding RVNC

# of Institutions
232
Shares Held
82.1M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email